Noticias de IMMP_US

Noticias del mercado

Últimas noticias sobre IMMP_US — 179 novedades recientes. Análisis, balances, opiniones y cobertura de prensa.

Ticker: IMMP_US ✕ 179 resultados
14/04/2026 IMMP_US — FinancialContent ES ← EN
ALERTA PARA INVERSORES: El bufete de abogados Pomerantz investiga reclamaciones en nombre de los inversores de Immutep Limited - IMMP
13/04/2026 IMMP_US — ACCESS Newswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Immutep Limited - IMMP
11/04/2026 IMMP_US — MSN
Immutep Limited - Depositary Receipt (IMMP) price target decreased by 72.36% to 0.98
09/04/2026 IMMP_US — MSN ES ← EN
Immutep Limited: el precio objetivo del recibo de depósito (IMMP) disminuyó un 72,36% a 0,98
09/04/2026 IMMP_US — PR Newswire ES ← EN
ALERTA PARA INVERSORES: El bufete de abogados Pomerantz investiga reclamaciones en nombre de los inversores de Immutep Limited - IMMP
09/04/2026 IMMP_US — ChartMill
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Immutep Limited - IMMP
09/04/2026 IMMP_US — Finansavisen
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Immutep Limited - IMMP
07/04/2026 IMMP_US — ChartMill
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Immutep Limited - IMMP
06/04/2026 IMMP_US — laocai.gov.vn
Is Immutep (IMMP) Stock at a Peak | Price at $0.36, Down 0.41% - Viral Momentum Stocks
02/04/2026 IMMP_US — Finansavisen
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Immutep Limited - IMMP
26/03/2026 IMMP_US — Finansavisen ES ← EN
ALERTA PARA INVERSORES: El bufete de abogados Pomerantz investiga reclamaciones en nombre de los inversores de Immutep Limited - IMMP
20/03/2026 IMMP_US — Business Wire
IMMP Investors Have Opportunity to Join Immutep Limited Fraud Investigation with the Schall Law Firm
20/03/2026 IMMP_US — TipRanks
Immutep Advances First-in-Class LAG-3 Agonist IMP761 With Positive Phase I Progress
19/03/2026 IMMP_US — Yahoo Finance
Immutep Reports Progress from Phase I Study of LAG-3 Agonist for Autoimmune Diseases
19/03/2026 IMMP_US — Stock Titan
Immutep (NASDAQ: IMMP) reports positive Phase I progress for LAG-3 agonist IMP761
19/03/2026 IMMP_US — Stock Titan ES ← EN
Immutep supera la primera etapa de dosificación de un fármaco autoinmune sin problemas de seguridad
19/03/2026 IMMP_US — The West Australian
ASX Runners of the Week: Immutep, Blue Star Helium & Patagonia
19/03/2026 IMMP_US — DirectorsTalk Interviews
Immutep Limited (IMMP) Stock Analysis: Navigating a Potential 140% Upside in the Biotech Sector
18/03/2026 IMMP_US — MarketScreener
Immutep updates market on TACTI-004 and pipeline priorities
18/03/2026 IMMP_US — TipRanks
Immutep Reports Positive Phase I Progress for First-in-Class Autoimmune Drug IMP761

Página 7 de 9

keyboard_arrow_up